申请人:Pharmacia & Tubjohn SPA
公开号:US06716856B1
公开(公告)日:2004-04-06
Compounds which are 4,5,6,7-tetrahydroindazole derivative formula (1), wherein the dotted line (x) represents a single or double bond; n is 0 or 1; R1, R2 and R3 have the meanings reported in the description; Ra, R′a, Rb, R′b, Rc, R′c have the meanings reported in the description, also comprising that Ra and Rb together and/or Ra and Rc together form a N-alkylpiperydinyl ring with 1 to 6 carbon atoms in the alkyl chain or a phenyl ring; or pharmaceutically acceptable salts thereof, are useful for treating cell proliferative disorders and Alzheimer's disease.
化合物是4,5,6,7-四氢吲唑衍生物公式(1),其中虚线(x)表示单键或双键;n为0或1;R1、R2和R3的含义如说明书所述;Ra、R'a、Rb、R'b、Rc、R'c的含义如说明书所述,还包括Ra和Rb一起和/或Ra和Rc一起形成具有1到6个碳原子的烷基链的N-烷基哌啶环或苯环;或其药学上可接受的盐,用于治疗细胞增殖性疾病和阿尔茨海默病。